IRIS
FERLAZZO, Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.943
AS - Asia 2.146
EU - Europa 1.700
SA - Sud America 381
AF - Africa 49
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 8
Totale 8.244
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.812
SG - Singapore 1.196
IT - Italia 690
CN - Cina 529
BR - Brasile 291
SE - Svezia 243
GB - Regno Unito 180
DE - Germania 175
VN - Vietnam 151
EE - Estonia 128
CA - Canada 88
IN - India 68
FI - Finlandia 62
HK - Hong Kong 60
UA - Ucraina 49
MX - Messico 34
AR - Argentina 33
ZA - Sudafrica 33
NL - Olanda 31
BD - Bangladesh 24
RU - Federazione Russa 24
TR - Turchia 22
ES - Italia 18
FR - Francia 16
ID - Indonesia 16
JP - Giappone 15
PL - Polonia 15
EC - Ecuador 14
RO - Romania 14
AU - Australia 13
IQ - Iraq 13
CO - Colombia 12
AT - Austria 11
CZ - Repubblica Ceca 11
SA - Arabia Saudita 11
PY - Paraguay 8
CH - Svizzera 7
GR - Grecia 7
PE - Perù 7
A2 - ???statistics.table.value.countryCode.A2??? 6
CL - Cile 6
VE - Venezuela 6
PK - Pakistan 5
IE - Irlanda 4
IL - Israele 4
JO - Giordania 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
ET - Etiopia 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
OM - Oman 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
KR - Corea 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
PW - Palau 1
RS - Serbia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 8.244
Salva come PNG Salva come JPEG
Città #
Singapore 587
Dallas 550
Chandler 544
Santa Clara 297
Hefei 289
Milan 261
Princeton 218
Lawrence 217
Chicago 141
Munich 139
Wilmington 135
London 128
Ashburn 103
Des Moines 72
Ho Chi Minh City 60
Hong Kong 60
Boardman 51
Ottawa 49
Los Angeles 44
Shanghai 42
Turku 39
Rome 35
Catanzaro 32
New York 32
São Paulo 30
Guangzhou 25
Hanoi 25
Helsinki 22
Seattle 19
Redwood City 18
San Francisco 17
Chennai 16
Genoa 16
Norwalk 16
The Dalles 16
Warsaw 15
Brooklyn 14
Johannesburg 14
Stockholm 14
Bologna 13
Charlotte 13
Pune 13
Atlanta 12
Mexico City 12
Naples 12
Rio de Janeiro 12
Columbus 11
Denver 11
Olomouc 11
Phoenix 11
Redmond 11
Boston 10
Council Bluffs 10
Da Nang 10
Tokyo 10
Toronto 10
Montreal 9
Thái Bình 9
Amsterdam 8
Assago 8
Dhaka 8
San Nicola Manfredi 8
Shenzhen 8
Ankara 7
Beijing 7
Cagliari 7
Casalnuovo Di Napoli 7
Gioia Tauro 7
Manchester 7
Bogotá 6
Cape Town 6
Catania 6
Ferrara 6
Kemerovo 6
Pelotas 6
Sydney 6
Thessaloniki 6
Wuhan 6
Bari 5
Boydton 5
Castiglion Fibocchi 5
Hanover 5
Las Vegas 5
Lima 5
Padova 5
Palermo 5
Quito 5
Timisoara 5
Vienna 5
Yiwu 5
Amman 4
Ann Arbor 4
Augusta 4
Brasília 4
Casalecchio di Reno 4
Chengdu 4
Guayaquil 4
Haiphong 4
Horia 4
Jakarta 4
Totale 4.848
Salva come PNG Salva come JPEG
Nome #
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 158
Genetics of reflex seizures and epilepsies in humans and animals 135
Epilessia occipitale con FOS in un paziente con calcificazioni cerebrali: studio clinico e video-EEG 124
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 124
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 116
A comprehensive machine-learning-based software pipeline to classify EEG signals: A case study on PNES vs. control subjects 99
Rating Scale for Psychogenic Non-epileptic Seizures: Scale Development and Clinimetric Testing 91
A network analysis based approach to characterizing periodic sharp wave complexes in electroencephalograms of patients with sporadic CJD. 74
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis. 72
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 67
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 66
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 65
About some behavioral and psychosocial aspects related to epilepsy. 62
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 61
A commercially available device suppresses photic driving: implications for EEG recording. 55
Asymmetry of Permutation Entropy in Early Creutzfeldt-Jakob Disease: A Clue to a Specific Pathological Process? 55
A new Italian instrument for the assessment of irritability in patients with epilepsy. 54
Lennox-Gastaut syndrome 53
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. 53
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study 53
Absence status epilepsy: delineation of a distinct idiopathic generalized epilepsy syndrome. 51
Long-term outcome of mild mesial temporal lobe epilepsy 50
Status epilepticus in pregnancy: a literature review and a protocol proposal 49
Teaching NeuroImages: Pseudohypertrophic cerebral cortex in end-stage Creutzfeldt-Jakob disease 49
Challenges in the pharmacological management of epilepsy and its causes in the elderly. 49
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 46
Epidemiology and outcomes of status epilepticus 45
Gestural automatisms during syncope related to cervical malignancy 44
An educational campaign about epilepsy among Italian primary school teachers. 2. The results of a focused training program. 44
Integrity of the corpus callosum in patients with benign temporal lobe epilepsy 44
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 43
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 43
Therapeutic approach to neurological manifestations of Angelman syndrome 43
Dystonia in Angelman syndrome: a common, unrecognized clinical finding 43
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 43
Myoclonic status epilepticus in patients with juvenile myoclonic epilepsy: Case reports and review of the literature 42
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 42
Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes 42
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 41
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia. 41
Rapid versus slow withdrawal of antiepileptic monotherapy in 2-year seizure-free adult patients with epilepsy (RASLOW) study: a pragmatic multicentre, prospective, randomized, controlled study. 40
Methodological issues associated with clinical trials in epilepsy 39
Diagnostic Biomarkers of Epilepsy 39
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording 39
Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy 38
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 38
Connectivity measures suggest a sub-cortical generator of myoclonus in Angelman syndrome 38
Deep learning representation from electroencephalography of early-stage creutzfeldt-jakob disease and features for differentiation from rapidly progressive dementia 38
Epilepsy in “Sunflower syndrome”: electroclinical features, therapeutic response, and long-term follow-up 38
Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy. 37
Permutation entropy of scalp EEG: A tool to investigate epilepsies: Suggestions from absence epilepsies. 37
Alterations in the α2 δ ligand, thrombospondin-1, in a rat model of spontaneous absence epilepsy and in patients with idiopathic/genetic generalized epilepsies. 37
Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. 37
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 36
Array-CGH in pazienti con epilessia e ritardo mentale 36
Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus 36
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 36
Botulism-induced unilateral submandibular sialoadenitis: a case report. 35
Successful treatment of Holmes tremor by levetiracetam. 35
Normal immunofluorescence pattern of skin basement membranes in a family with porencephaly due to COL4A1 G749S mutation 35
Value of clinical features to differentiate refractory epilepsy from mimics: a prospective longitudinal cohort study. 35
Cerebral toxoplasmosis diagnosed by brain tissue PCR analysis in an immunocompetent patient 35
Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy 35
Autosomal recessive progressive myoclonus epilepsy due to impaired ceramide synthesis. 35
Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease 35
Effectiveness of Perampanel as the Only Add-on: Retrospective, Multicenter, Observational Real Life Study on epilepsy patients 34
Alien hand syndrome-like functional seizures in a patient with right temporo-parietal damage and neurocognitive disorder: a case report 34
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 34
Unverricht-Lundborg disease. 34
Genome-wide linkage meta-analysis identifies susceptibility loci at 2q34 and 13q31.3 for genetic generalized epilepsies. 34
Mild Lafora disease: Clinical, neurophysiologic, and genetic findings. 34
Oxcarbazepine-related male infertility 34
Familial idiopathic generalized epilepsy: description of an unusual phenotype in a family. 34
Automated shape analysis improves the detection of hippocampal damage in patients with temporal lobe epilepsy 34
The hidden link between late-onset seizures and cerebral amyloid angiopathy: A case-control study 33
Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs 33
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) 33
Dose-dependent oxcarbazepine-related anorgasmia 33
Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals 33
Incidence of early poststroke seizures during reperfusion therapies in patients with acute ischemic stroke: An observational prospective study: (TESI study: “Trombolisi/Trombectomia e crisi Epilettiche precoci nello Stroke Ischemico”) 33
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 33
Energy drinks and seizures: what is the link? 32
Lacosamide in Lennox-Gastaut Syndrome? Caution Is Still Needed. 32
A pilot open-label trial of zonisamide in Unverricht-Lundborg disease. 32
Profile of brivaracetam and its potential in the treatment of epilepsy 32
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy 32
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 32
Permutation Entropy-Based Interpretability of Convolutional Neural Network Models for Interictal EEG Discrimination of Subjects with Epileptic Seizures vs. Psychogenic Non-Epileptic Seizures 32
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy 32
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 31
Idiopatic familial trigeminal neurolgia: a case report 31
Epileptogenic role of occult temporal encephalomeningocele: Case-control study. 31
Exome sequencing reveals two FA2H mutations in a family with a complicated form of Hereditary Spastic Paraplegia and psychiatric impairments. 31
Seizures with Migraine-like Attacks after Radiation Therapy (SMART): A new meaning of an old acronym. 31
Continuous spikes and waves during slow sleep in a child with karyotype 47, XYY. 31
EpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation process. 31
Detection of hippocampal atrophy in patients with temporal lobe epilepsy: a 3-Tesla MRI shape. 31
Progressive myoclonic epilepsies: definitive and still undetermined causes. 31
An educational campaign toward epilepsy among Italian primary school teachers: 1. Survey on knowledge and attitudes 31
Cryptogenic cerebral venous thrombosis in a multiple-sclerosis-patient treated with Alemtuzumab 31
Totale 4.584
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.973
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 7 44 19 18 8 18 96 10 1 6
2021/2022659 5 2 11 170 72 8 12 148 58 59 112 2
2022/20231.639 440 27 60 154 174 160 8 115 258 111 112 20
2023/2024809 146 113 71 61 54 162 33 33 22 22 25 67
2024/20253.151 404 253 154 136 152 418 101 86 356 268 279 544
2025/20261.894 312 697 885 0 0 0 0 0 0 0 0 0
Totale 8.508